NEW YORK (GenomeWeb News) – Molecular biology enzymes manufacturer Enzymatics today said that it has received ISO 13485:2003 and 9001:2000 standards certification from TÜV SÜD America.

The Beverly, Mass.-based firm makes proteins that are used for research and diagnostics purposes with a focus on nucleic acid detection technologies. It provides enzymes and buffer solutions for the Polonator, a low-cost sequencing system developed by George Church's group at Harvard Medical School and sold by the Dover unit of Danaher-Motion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.